Haemonetics Operating Income 2010-2023 | HAE

Haemonetics operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Haemonetics Annual Operating Income
(Millions of US $)
2023 $156
2022 $81
2021 $90
2020 $103
2019 $84
2018 $56
2017 $-19
2016 $-44
2015 $41
2014 $46
2013 $56
2012 $89
2011 $111
2010 $83
2009 $86
Haemonetics Quarterly Operating Income
(Millions of US $)
2023-12-31 $46
2023-09-30 $35
2023-06-30 $54
2023-03-31 $35
2022-12-31 $43
2022-09-30 $47
2022-06-30 $31
2022-03-31 $19
2021-12-31 $36
2021-09-30 $25
2021-06-30 $1
2021-03-31 $-21
2020-12-31 $40
2020-09-30 $59
2020-06-30 $12
2020-03-31 $26
2019-12-31 $41
2019-09-30 $50
2019-06-30 $-13
2019-03-31 $24
2018-12-31 $28
2018-09-30 $26
2018-06-30 $5
2018-03-31 $14
2017-12-31 $1
2017-09-30 $24
2017-06-30 $17
2017-03-31 $-58
2016-12-31 $21
2016-09-30 $25
2016-06-30 $-8
2016-03-31 $-6
2015-12-31 $-61
2015-09-30 $19
2015-06-30 $4
2015-03-31 $12
2014-12-31 $18
2014-09-30 $12
2014-06-30 $-2
2014-03-31 $12
2013-12-31 $18
2013-09-30 $23
2013-06-30 $-7
2013-03-31 $18
2012-12-31 $16
2012-09-30 $10
2012-06-30 $13
2012-03-31 $21
2011-12-31 $25
2011-09-30 $19
2011-06-30 $24
2011-03-31 $29
2010-12-31 $29
2010-09-30 $29
2010-06-30 $24
2010-03-31 $4
2009-12-31 $26
2009-09-30 $27
2009-06-30 $26
2009-03-31 $18
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.275B $1.169B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $189.499B 24.60
Stryker (SYK) United States $128.469B 31.85
Medtronic (MDT) Ireland $105.230B 14.90
Boston Scientific (BSX) United States $99.939B 33.23
EssilorLuxottica (ESLOY) France $98.203B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.924B 0.00
Haleon (HLN) United Kingdom $36.986B 28.93
ResMed (RMD) United States $27.191B 27.18
Terumo (TRUMY) Japan $25.327B 35.77
Zimmer Biomet Holdings (ZBH) United States $25.081B 16.15
Baxter (BAX) United States $20.095B 14.66
Koninklijke Philips (PHG) Netherlands $18.879B 15.06
Insulet (PODD) United States $12.094B 63.50
Smith & Nephew SNATS (SNN) United Kingdom $10.404B 0.00
Demant (WILYY) Denmark $10.151B 0.00
Bio-Rad Laboratories (BIO) United States $8.349B 24.87
BellRing Brands (BRBR) United States $7.231B 38.88
Lantheus Holdings (LNTH) United States $4.232B 10.93
Perrigo (PRGO) Ireland $4.060B 11.61
GN Store Nord (GNNDY) Denmark $3.675B 23.80
Envista Holdings (NVST) United States $3.399B 12.93
Prestige Consumer Healthcare (PBH) United States $3.379B 15.98
QuidelOrtho (QDEL) United States $2.695B 9.78
Neogen (NEOG) United States $2.634B 25.33
Green Thumb Industries (GTBIF) United States $2.613B 82.80
ICU Medical (ICUI) United States $2.347B 17.51
TG Therapeutics (TGTX) United States $2.162B 700.00
Maravai LifeSciences Holdings (MRVI) United States $2.046B 0.00
Owens & Minor (OMI) United States $1.903B 18.27
Verano Holdings (VRNOF) United States $1.686B 0.00
Agios Pharmaceuticals (AGIO) United States $1.618B 0.00
InMode (INMD) Israel $1.480B 7.66
National Vision Holdings (EYE) United States $1.479B 46.05
LeMaitre Vascular (LMAT) United States $1.430B 47.50
AdaptHealth (AHCO) United States $1.277B 9.61
Warby Parker (WRBY) United States $1.241B 0.00
AtriCure (ATRC) United States $1.117B 0.00
MacroGenics (MGNX) United States $1.044B 0.00
BioLife Solutions (BLFS) United States $0.725B 0.00
Cresco Labs (CRLBF) United States $0.709B 0.00
Evolus (EOLS) United States $0.698B 0.00
VAREX IMAGING (VREX) United States $0.698B 15.07
Jin Medical (ZJYL) China $0.673B 0.00
Canopy Growth (CGC) Canada $0.610B 0.00
Quanterix (QTRX) United States $0.610B 0.00
Valneva SE (VALN) France $0.556B 0.00
Phibro Animal Health (PAHC) United States $0.526B 11.40
TerrAscend (TSNDF) Canada $0.510B 0.00
PetIQ (PETQ) United States $0.477B 17.80
ZimVie (ZIMV) United States $0.427B 26.15
Biote (BTMD) United States $0.426B 4.05
OraSure Technologies (OSUR) United States $0.399B 6.61
Zynex (ZYXI) United States $0.391B 45.00
Surmodics (SRDX) United States $0.379B 40.92
Aurora Cannabis (ACB) Canada $0.322B 0.00
Viemed Healthcare (VMD) United States $0.320B 31.77
Cerus (CERS) United States $0.305B 0.00
Sanara MedTech (SMTI) United States $0.273B 0.00
TriSalus Life Sciences (TLSI) United States $0.253B 0.00
Utah Medical Products (UTMD) United States $0.244B 14.91
Omeros (OMER) United States $0.199B 0.00
Ayr Wellness (AYRWF) United States $0.195B 0.00
Organigram Holdings (OGI) Canada $0.194B 0.00
Capricor Therapeutics (CAPR) United States $0.187B 0.00
Veru (VERU) United States $0.184B 0.00
High Tide (HITI) Canada $0.177B 0.00
Quipt Home Medical (QIPT) United States $0.158B 0.00
FitLife Brands (FTLF) United States $0.132B 21.19
Jushi Holdings (JUSHF) United States $0.128B 0.00
Eagleford Energy (GRUSF) United States $0.125B 62.70
Allurion Technologies (ALUR) United States $0.113B 0.00
InterCure (INCR) Israel $0.108B 18.23
Cellectar Biosciences (CLRB) United States $0.107B 0.00
Fonar (FONR) United States $0.106B 9.12
Safety Shot (SHOT) United States $0.102B 0.00
MariMed (MRMD) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Brainsway (BWAY) Israel $0.085B 0.00
Chimerix (CMRX) United States $0.082B 0.00
Zevia PBC (ZVIA) United States $0.072B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.061B 3.97
Apyx Medical (APYX) United States $0.048B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
Cytosorbents (CTSO) United States $0.043B 0.00
Bright Green (BGXX) United States $0.041B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.036B 13.91
Modular Medical (MODD) United States $0.034B 0.00
Exagen (XGN) United States $0.025B 0.00
Nephros (NEPH) United States $0.021B 0.00
FSD PHARMA (HUGE) Canada $0.020B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Agape ATP (ATPC) $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 71.36
ProSomnus (OSA) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00